Impact of anti-diabetic sodium-glucose cotransporter 2 inhibitors on tumor growth of intractable hematological malignancy in humans-Reference-Cited by-同舟云学术

Impact of anti-diabetic sodium-glucose cotransporter 2 inhibitors on tumor growth of intractable hematological malignancy in humans

Published:2022-05 Issue: Volume:149 Page:112864
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Nakachi Sawako,Okamoto Shiki,Tamaki Keita,Nomura Ikumi,Tomihama Mamiko,Nishi Yukiko,Fukushima Takuya,Tanaka Yuetsu,Morishima Satoko,Imamura Minako,Maeda Shiro,Tsutsui Masato,Matsushita Masayuki,Masuzaki Hiroaki

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference45 articles.

1. Why do cancers have high aerobic glycolysis?;Gatenby;Nat. Rev. Cancer,2004

2. Metabolic reprogramming for cancer cells and their microenvironment: beyond the Warburg effect;Sun;Biochim. Et. Biophys. Acta Rev. Cancer,2018

3. The Warburg effect: how does it benefit cancer cells?;Liberti;Trends Biochem. Sci.,2016

4. Crucial role of the pentose phosphate pathway in malignant tumors;Jin;Oncol. Lett.,2019

5. Understanding the Warburg effect: the metabolic requirements of cell proliferation;Vander Heiden;Science,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond;Basic Research in Cardiology;2024-06-27

2. Deciphering the Causal Relationship between Sodium-glucose Cotransporter 2 Inhibition and Cancer Risks: A Comprehensive Mendelian Randomization Study;Journal of Cancer;2024

3. Molecular Aspects ofC-glycosides: Interactive Analysis of C-linked Compounds With the SGLT2 Molecular Model;Anticancer Research;2023-07-26

4. Cancer related safety with SGLT2-i and GLP1-RAs: Should we worry?;Diabetes Research and Clinical Practice;2023-04

5. Adenosine signaling: Optimal target for gastric cancer immunotherapy;Frontiers in Immunology;2022-09-16